CAM
TECH icon

Cresset Asset Management’s Bio-Techne TECH Stock Holding History

Cresset Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52M Sell
736,708
-2,483
-0.3% -$134K 0.19% 86
2026
Q1 		$38.6M Buy
739,191
+45,568
+7% +$2.74M 0.17% 92
2025
Q4 		$40.8M Buy
693,623
+52,838
+8% +$3.21M 0.17% 90
2025
Q3 		$35.6M Buy
640,785
+16,493
+3% +$883K 0.16% 90
2025
Q2 		$32.1M Buy
624,292
+20,150
+3% +$1.01M 0.16% 90
2025
Q1 		$35.4M Buy
604,142
+414,186
+218% +$28.1M 0.18% 88
2024
Q4 		$13.7M Sell
189,956
-44,553
-19% -$3.27M 0.07% 186
2024
Q3 		$18.7M Buy
234,509
+5,776
+3% +$434K 0.07% 177
2024
Q2 		$16.4M Buy
228,733
+16,285
+8% +$1.2M 0.07% 184
2024
Q1 		$15M Buy
212,448
+108,980
+105% +$7.8M 0.07% 188
2023
Q4 		$7.98M Buy
103,468
+66,943
+183% +$4.41M 0.05% 249
2023
Q3 		$2.49M Buy
36,525
+810
+2% +$64K 0.01% 478
2023
Q2 		$2.92M Buy
35,715
+17,448
+96% +$1.4M ﹤0.01% 535
2023
Q1 		$1.36M Buy
+18,267
New +$1.41M 0.03% 287
2022
Q4 		– Sell
-20,356
Closed -$1.45M – 879
2022
Q3 		$1.45M Buy
20,356
+696
+4% +$60.1K 0.02% 273
2022
Q2 		$1.7M Buy
+19,660
New +$1.84M 0.02% 255
2022
Q1 		– Sell
-1,832
Closed -$238K – 1134
2021
Q4 		$238K Sell
1,832
-5,336
-74% -$654K ﹤0.01% 977
2021
Q3 		$868K Buy
7,168
+3,748
+110% +$456K 0.01% 439
2021
Q2 		$386K Buy
3,420
+192
+6% +$20.2K 0.01% 653
2021
Q1 		$309K Buy
3,228
+336
+12% +$30.7K ﹤0.01% 662
2020
Q4 		$230K Buy
+2,892
New +$209K ﹤0.01% 661

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cresset Asset Management's TECH Position: Q2 2026 in Review

Cresset Asset Management reduced its Bio-Techne (TECH) stake by 0.34% in Q2 2026, selling an estimated $134K and leaving 736,708 shares worth $52M. The position accounts for 0.19% of the portfolio, ranked #86.

Cresset Asset Management first reported a position in TECH in Q4 2020 and has held it in 21 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cresset Asset Management held 736,708 shares of Bio-Techne worth $52M as of Q2 2026.
  • Cresset Asset Management sold 2,483 Bio-Techne shares in Q2 2026, an estimated $134K.
  • Bio-Techne made up 0.19% of Cresset Asset Management's portfolio in Q2 2026, its #86 holding.
  • Cresset Asset Management first reported a position in Bio-Techne in Q4 2020 and has held it in 21 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.